waypoint wealth counsel »

Ironwood Pharmaceuticals shares owned by waypoint wealth counsel

Quarter-by-quarter ownership of Ironwood Pharmaceuticals (IRWD) shares owned by waypoint wealth counsel from 13F filings

Historical chart of waypoint wealth counsel investment in Ironwood Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ironwood Pharmaceuticals held by waypoint wealth counsel consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ironwood Pharmaceuticals by waypoint wealth counsel

Quarter filed Position value Share count Share price at filing
2025-09-30 $17k 13k 1.31

More positions owned by waypoint wealth counsel

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Whitehall Fds High Div Yld (VYM)
Spdr Gold Tr Gold Shs (GLD)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Coca-Cola Company (KO)
Ishares Gold Tr Ishares New (IAU)
NVIDIA Corporation (NVDA)
Ishares Tr Russell 2000 Etf (IWM)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr S&p 500 Grwt Etf (IVW)
Amazon (AMZN)

View all positions for waypoint wealth counsel

Top funds holding Ironwood Pharmaceuticals

Armistice Capital
Vanguard Group
Sarissa Capital Management
BlackRock
UBS Group
Renaissance Technologies
Acadian Asset Management
Kynam Capital Management
AQR Capital Management
Charles Schwab Investment Management
Geode Capital Management
Two Sigma Advisers
State Street Corporation
Marshall Wace
Qube Research & Technologies

View all funds holding Ironwood Pharmaceuticals